{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01185132",
            "orgStudyIdInfo": {
                "id": "2009-APBI"
            },
            "secondaryIdInfos": [
                {
                    "id": "WIRB #20091193",
                    "type": "OTHER",
                    "domain": "Western IRB"
                }
            ],
            "organization": {
                "fullName": "Rocky Mountain Cancer Centers",
                "class": "OTHER"
            },
            "briefTitle": "Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy",
            "officialTitle": "A Phase III Randomized Study Comparing Intensity Modulated Planning Versus 3-Dimensional Planning for Accelerated Partial Breast Radiotherapy",
            "acronym": "2009-APBI",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "intensity-modulated-radiotherapy-imrt-vs-conformal-accelerated-partial-breast-irradiation-apbi-for-early-stage-breast-cancer-after-lumpectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2014-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2009-07"
            },
            "primaryCompletionDateStruct": {
                "date": "2018-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2010-08-18",
            "studyFirstSubmitQcDate": "2010-08-18",
            "studyFirstPostDateStruct": {
                "date": "2010-08-19",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2014-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2014-06-26",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Rocky Mountain Cancer Centers",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer"
            ],
            "keywords": [
                "breast-conservation",
                "adjuvant radiotherapy",
                "breast cancer",
                "early-stage breast cancer",
                "DCIS",
                "lumpectomy",
                "accelerated partial breast irradiation",
                "APBI",
                "three dimensional conformal external radiotherapy",
                "intensity modulated radiotherapy",
                "3D CRT",
                "IMRT"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 660,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IMRT",
                    "type": "EXPERIMENTAL",
                    "description": "Intensity modulated radiotherapy, 38.5 Gy, 10 fractions over 5 days",
                    "interventionNames": [
                        "Radiation: accelerated partial breast irradiation - IMRT planning"
                    ]
                },
                {
                    "label": "3D-CRT",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Three dimensional conformal external radiotherapy, 38.5 Gy, 10 fractions over 5 days",
                    "interventionNames": [
                        "Radiation: accelerated partial breast irradiation - 3D-conformal planning"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "accelerated partial breast irradiation - 3D-conformal planning",
                    "description": "38.5 Gy, 10 fractions over 5 days",
                    "armGroupLabels": [
                        "3D-CRT"
                    ],
                    "otherNames": [
                        "APBI",
                        "EBRT"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "accelerated partial breast irradiation - IMRT planning",
                    "description": "38.5 Gy, 10 fractions over 5 days",
                    "armGroupLabels": [
                        "IMRT"
                    ],
                    "otherNames": [
                        "APBI",
                        "EBRT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Prevalence of breast pain after Accelerated Partial Breast Radiotherapy (APBI)",
                    "description": "Assessment by both treating investigators and by subjective patient outcomes questionnaires filled out at each follow-up visit",
                    "timeFrame": "5 years"
                },
                {
                    "measure": "Prevalence of chest wall pain after Accelerated Partial Breast Radiotherapy (APBI)",
                    "description": "Assessment by both treating investigators and by subjective patient outcomes questionnaires filled out at each follow-up visit",
                    "timeFrame": "2-5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Dosimetric comparison",
                    "description": "Comparison of treatment plans and actual doses received between comparable patients treated with 3D-CRT and IMRT with regard to treatment target and normal tissue",
                    "timeFrame": "5-10 days"
                },
                {
                    "measure": "Acute skin reactions",
                    "description": "Radiation-induced dermatitis",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Cosmetic outcomes after APBI",
                    "description": "Assesed by both treating investigators and subjective patient questionnaires filled out at each follow-up visit",
                    "timeFrame": "2-5 years"
                },
                {
                    "measure": "Ipsilateral breast event",
                    "description": "Track occurrence and patterns of local treatment failures or new primaries within the treated breast (efficacy outcome measure)",
                    "timeFrame": "5-15 years"
                },
                {
                    "measure": "Cause specific survival",
                    "description": "Track survival status and the specific cause(s) of death if applicable for study participants (efficacy outcome measure)",
                    "timeFrame": "5-15 years"
                },
                {
                    "measure": "Disease free survival",
                    "description": "Track breast-cancer free survival status of study participants (efficacy outcome measure)",
                    "timeFrame": "5-15 years"
                },
                {
                    "measure": "Overall survival",
                    "description": "Track the overall survival status of all study participants (efficacy outcome measure)",
                    "timeFrame": "5-15 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed disease (AJC Classification): Tis, T1, T2 (\u2264 3.0 cm), N0, M0.\n* Microscopic multifocal disease is only allowed when the entire span of identified disease measures 3.0 cm or less.\n* Negative surgical margins ( \u2265 0.2 cm) after final surgery.\n* Subjects with infiltrating lobular histologies or high nuclear grade DCIS will be required to have breast MRI scanning as part of the initial staging to verify localized disease.\n* Subjects with DCIS will be included in the study only if they had an MRI prior to lumpectomy.\n* Findings on MRI scanning revealing relevant suspicion of disease outside of planned lumpectomy volume should be further evaluated by ultrasound and, if necessary biopsy, to exclude multicentric/multifocal disease.\n* Subjects with malignant calcifications on mammography will be required to have repeat mammography after surgery to ensure removal of all malignant calcifications.\n* Willing to complete additional screening requirements and meet eligibility criteria as defined in protocol Sec. 4.4.\n* Successful placement of fiducial markers for IGRT requiring nonmigrating fiducials.\n* PTV to ipsilateral breast ratio (IBR) \u2264 25 %.\n* Radiotherapy anticipated to begin within 10 weeks of lumpectomy or re-excision of margins.\n\nExclusion Criteria:\n\n* Pregnancy or breast-feeding.\n* Have collagen-vascular disease.\n* Inadequate surgical margins ( \\< 0.2 cm) after final surgery.\n* Subjects with persistent malignant/suspicious micro-calcifications.\n* Gross multifocal disease and microscopic disease greater than 3.0 cm.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "40 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rachel Lei, BS",
                    "role": "CONTACT",
                    "phone": "303-418-7607",
                    "email": "rachel.lei@usoncology.com"
                },
                {
                    "name": "Charles Leonard, MD",
                    "role": "CONTACT",
                    "phone": "303-730-4700"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Charles Leonard, MD",
                    "affiliation": "Rocky Mountain Cancer Centers",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Rocky Mountain Cancer Centers - Aurora",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80012",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dennis Carter, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "William Daniel, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Kathryn Howell, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers - Boulder",
                    "status": "RECRUITING",
                    "city": "Boulder",
                    "state": "Colorado",
                    "zip": "80303",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrew Antell, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Meera Patel, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Ralph Wright, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.01499,
                        "lon": -105.27055
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers - Lakewood",
                    "status": "RECRUITING",
                    "city": "Lakewood",
                    "state": "Colorado",
                    "zip": "80228",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ralph Wright, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Charles Leonard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.70471,
                        "lon": -105.08137
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers - Littleton",
                    "status": "RECRUITING",
                    "city": "Littleton",
                    "state": "Colorado",
                    "zip": "80120",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Charles Leonard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Kathryn Howell, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.61332,
                        "lon": -105.01665
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers - Thornton",
                    "status": "RECRUITING",
                    "city": "Thornton",
                    "state": "Colorado",
                    "zip": "80260",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robert LaPorte, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Daniel Chin, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.86804,
                        "lon": -104.97192
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34469056",
                    "type": "DERIVED",
                    "citation": "Leonard CE, Wang Y, Asmar L, Lei RY, Howell KT, Henkenberns PL, Johnson TK, Hobart TL, Tole SP, Kercher JM, Widner JL, Barke L, Kaske T, Carter DL. A prospective Phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy. Cancer Med. 2021 Oct;10(20):7089-7100. doi: 10.1002/cam4.4242. Epub 2021 Sep 1."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}